Literature DB >> 16153597

Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis.

Kangseok Lee1, Margareta D Pisarska, Jeong-Jae Ko, Yeongseup Kang, Seongmin Yoon, Sang-Mi Ryou, Kwang-Yul Cha, Jeehyeon Bae.   

Abstract

Blepharophimosis-ptosis-epicanthus inversus syndrome type I is an autosomal disorder caused by mutations in FOXL2 gene and associated with premature ovarian failure in women by a dominant inheritance. FOXL2 is a recently identified protein that belongs to forkhead family transcription factor, of which signaling pathways are still unknown. Here, we show that FOXL2 induces apoptosis in both Chinese hamster ovary cells and rat granulosa cells, and it interacts with DP103, a DEAD box-containing protein. Overexpression of DP103 itself did not affect cell viability while its coexpression with FOXL2 led to the potentiation of cell death. Our results present previously undiscovered functions of these proteins, an apoptotic activity of FOXL2 in the ovary and a modulating activity of DP103 by interacting with FOXL2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153597     DOI: 10.1016/j.bbrc.2005.08.184

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

2.  FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells.

Authors:  Mira Park; Eunkyoung Shin; Miae Won; Jae-Hong Kim; Hayoung Go; Hyun-Lee Kim; Jeong-Jae Ko; Kangseok Lee; Jeehyeon Bae
Journal:  Mol Endocrinol       Date:  2010-03-05

3.  Abnormal interaction of motor neuropathy-associated mutant HspB8 (Hsp22) forms with the RNA helicase Ddx20 (gemin3).

Authors:  Xiankui Sun; Jean-Marc Fontaine; Adam D Hoppe; Serena Carra; Cheryl DeGuzman; Jody L Martin; Stephanie Simon; Patrick Vicart; Michael J Welsh; Jacques Landry; Rainer Benndorf
Journal:  Cell Stress Chaperones       Date:  2010-02-17       Impact factor: 3.667

4.  Correlation analysis between gene expression profile of rat liver tissues and high-fat emulsion-induced nonalcoholic fatty liver.

Authors:  Cunshuan Xu; Gaiping Wang; Yunpeng Hao; Jia Zhi; Lianxing Zhang; Cuifang Chang
Journal:  Dig Dis Sci       Date:  2011-02-17       Impact factor: 3.199

Review 5.  Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology.

Authors:  Margareta D Pisarska; Gillian Barlow; Fang-Ting Kuo
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

6.  Inhibition of U snRNP assembly by a virus-encoded proteinase.

Authors:  Laura L Almstead; Peter Sarnow
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

7.  Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene.

Authors:  Fang-Ting Kuo; Ikuko K Bentsi-Barnes; Gillian M Barlow; Jeehyeon Bae; Margareta D Pisarska
Journal:  Cell Signal       Date:  2009-09-08       Impact factor: 4.315

8.  FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells.

Authors:  Martina Belli; Nahoko Iwata; Tomoko Nakamura; Akira Iwase; Dwayne Stupack; Shunichi Shimasaki
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

9.  FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.

Authors:  David E Joyner; Sylvia H Trang; Albert J Aboulafia; Timothy A Damron; R L Randall; R Lor Randall
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

10.  DEAD-box protein-103 (DP103, Ddx20) is essential for early embryonic development and modulates ovarian morphology and function.

Authors:  Jean-François Mouillet; Xiaomei Yan; Qinglin Ou; Lingling Jin; Louis J Muglia; Peter A Crawford; Yoel Sadovsky
Journal:  Endocrinology       Date:  2008-02-07       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.